Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Late cornified envelope protein 1E (LCE1E) is a structurally specialized protein found in the upper layers of the epidermis, where it becomes covalently cross-linked to other proteins during the final stages of keratinocyte terminal differentiation, forming the cornified cell envelope[1][2]. LCE1E is a member of the LCE1 family, encoded within the epidermal differentiation complex on chromosome 1q21. Its expression is induced late in epidermal maturation, and it is incorporated into the cornified envelope via transglutaminase-mediated cross-linking, contributing to the mechanical resilience and barrier properties of the skin[1][2]. While not itself a therapeutic target, LCE1E and related late cornified envelope proteins play a compensatory role when other barrier proteins such as loricrin are absent, and their abnormal regulation has been implicated in the pathophysiology of skin barrier defects[1]. There are no known drug interactions, direct mechanistic actions, or established biomarker or safety concerns associated with LCE1E.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Late cornified envelope protein 1E (LCE1E).